↓ Skip to main content

Inflammatory activation: cardiac, renal, and cardio-renal interactions in patients with the cardiorenal syndrome

Overview of attention for article published in Heart Failure Reviews, June 2011
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (71st percentile)
  • High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

twitter
3 X users
patent
2 patents

Citations

dimensions_citation
168 Dimensions

Readers on

mendeley
127 Mendeley
Title
Inflammatory activation: cardiac, renal, and cardio-renal interactions in patients with the cardiorenal syndrome
Published in
Heart Failure Reviews, June 2011
DOI 10.1007/s10741-011-9261-3
Pubmed ID
Authors

Paolo C. Colombo, Anjali Ganda, Jeffrey Lin, Duygu Onat, Ante Harxhi, Julia E. Iyasere, Nir Uriel, Gad Cotter

Abstract

Although inflammation is a physiologic response designed to protect us from infection, when unchecked and ongoing it may cause substantial harm. Both chronic heart failure (CHF) and chronic kidney disease (CKD) are known to cause elaboration of several pro-inflammatory mediators that can be detected at high concentrations in the tissues and blood stream. The biologic sources driving this chronic inflammatory state in CHF and CKD are not fully established. Traditional sources of inflammation include the heart and the kidneys which produce a wide range of pro-inflammatory cytokines in response to neurohormones and sympathetic activation. However, growing evidence suggests that non-traditional biomechanical mechanisms such as venous and tissue congestion due to volume overload are also important as they stimulate endotoxin absorption from the bowel and peripheral synthesis and release of pro-inflammatory mediators. Both during the chronic phase and, more rapidly, during acute exacerbations of CHF and CKD, inflammation and congestion appear to amplify each other resulting in a downward spiral of worsening cardiac, vascular, and renal functions that may negatively impact patients' outcome. Anti-inflammatory treatment strategies aimed at attenuating end organ damage and improving clinical prognosis in the cardiorenal syndrome have been disappointing to date. A new therapeutic paradigm may be needed, which involves different anti-inflammatory strategies for individual etiologies and stages of CHF and CKD. It may also include specific (short-term) anti-inflammatory treatments that counteract inflammation during the unsettled phases of clinical decompensation. Finally, it will require greater focus on volume overload as an increasingly significant source of systemic inflammation in the cardiorenal syndrome.

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 127 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 <1%
New Zealand 1 <1%
Austria 1 <1%
Brazil 1 <1%
Unknown 123 97%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 23 18%
Student > Ph. D. Student 17 13%
Student > Master 17 13%
Researcher 14 11%
Student > Postgraduate 10 8%
Other 20 16%
Unknown 26 20%
Readers by discipline Count As %
Medicine and Dentistry 55 43%
Biochemistry, Genetics and Molecular Biology 12 9%
Agricultural and Biological Sciences 9 7%
Nursing and Health Professions 4 3%
Psychology 4 3%
Other 18 14%
Unknown 25 20%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 February 2023.
All research outputs
#5,915,552
of 23,454,152 outputs
Outputs from Heart Failure Reviews
#173
of 682 outputs
Outputs of similar age
#32,569
of 115,884 outputs
Outputs of similar age from Heart Failure Reviews
#2
of 10 outputs
Altmetric has tracked 23,454,152 research outputs across all sources so far. This one has received more attention than most of these and is in the 74th percentile.
So far Altmetric has tracked 682 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.1. This one has gotten more attention than average, scoring higher than 74% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 115,884 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 71% of its contemporaries.
We're also able to compare this research output to 10 others from the same source and published within six weeks on either side of this one. This one has scored higher than 8 of them.